Elevance Health Reports Strong Second Quarter 2024 Results, Raises Full Year Outlook

Financial Performance Highlights

Elevance Health, Inc., a prominent player in the health benefits sector, has announced impressive financial results for the second quarter of 2024. The company reported a significant increase in its key financial metrics, demonstrating strong performance across its business segments 1

1

GAAP net income for Q2 2024 stood at $1.8 billion, or $7.59 per share, marking a substantial improvement from the previous year. On an adjusted basis, net income reached $2.1 billion, or $9.04 per share, exceeding analysts' expectations 2

2

Operating revenue for the quarter surged to $42.3 billion, representing a 7.4% increase compared to the same period in 2023. This growth was primarily driven by higher premium revenue in Elevance Health's Health Benefits business and expanded membership in its Government Business segment 3

3

Membership Growth and Business Segment Performance

Elevance Health reported a total medical membership of 47.3 million as of June 30, 2024, reflecting an increase of 1.1 million members, or 2.4%, from the previous year. The company's Government Business segment, which includes Medicare and Medicaid plans, showed particularly strong growth 1

1

The Health Benefits segment also performed well, with operating revenue increasing by 5.9% to $26.1 billion. This growth was attributed to premium rate increases to cover overall cost trends and membership growth in the Commercial & Specialty Business division 2

2

Improved Medical Cost Performance

Elevance Health reported a benefit expense ratio of 86.3% for Q2 2024, an improvement of 20 basis points from the same period in 2023. This metric indicates the company's ability to effectively manage medical costs while maintaining quality care for its members 3

3

Outlook and Guidance

Based on the strong performance in the first half of 2024, Elevance Health has raised its full-year outlook. The company now expects adjusted net income to be greater than $36.00 per share, up from the previous guidance of greater than $35.60 per share 1

1

Related Stories

Energy and Financial Services Companies Report Strong Q2 2024 Results

Q2 2024 Financial Results: iHeartMedia, Outbrain, and GoHealth Show Mixed Performance

C.H. Robinson and Cross Country Healthcare Report Q2 2024 Financial Results

HCA Healthcare Reports Strong Second Quarter 2024 Results

Executive Commentary

Gail K. Boudreaux, President and CEO of Elevance Health, expressed satisfaction with the company's performance, stating, "Our strong second quarter results reflect continued momentum across all of our businesses as we advance our strategy to become a lifetime, trusted health partner." She emphasized the company's focus on delivering affordable, personalized healthcare solutions to its members 2

2

Market Response

Following the announcement of the Q2 2024 results, Elevance Health's stock price showed positive movement in pre-market trading. Investors and analysts have responded favorably to the company's strong performance and improved outlook for the full year 3

3